These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 329806)

  • 21. [Effects of stimulation on the longitudal resistance of the myocardium].
    Garcia EA; Carvalho AP
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():7-22. PubMed ID: 889474
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction.
    Angus JA; Richmond DR; Dhumma-Upakorn P; Cobbin LB; Goodman AH
    Cardiovasc Res; 1976 Nov; 10(6):623-32. PubMed ID: 991162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular and electrocardiographic responses to verapamil in dogs.
    Lawson NW; Kraynack BJ; Gintautas J
    Anesth Analg; 1983 Jan; 62(1):50-4. PubMed ID: 6849509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of calcium antagonists in the therapy of coronary heart disease].
    Meyer J
    Internist (Berl); 1983 Jul; 24(7):408-14. PubMed ID: 6136492
    [No Abstract]   [Full Text] [Related]  

  • 25. Verapamil toxicity causing anterograde atrioventricular blockade with preserved retrograde conduction: An electrophysiological paradox.
    Jacob S; Bharadwaj AS; Ganguly J; Kottam A
    Cardiol J; 2010; 17(6):636-7. PubMed ID: 21154272
    [No Abstract]   [Full Text] [Related]  

  • 26. Action of a calcium blocking agent (D600) on electrogenesis in the normal heart and the ischaemic heart in the dog.
    Van Bogaert A; De Schepper J
    Acta Cardiol; 1982; 37(3):183-97. PubMed ID: 6289576
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphofunctional analysis of the efficacy of verapamil in experimental ischemia].
    Bratus' VV; Sergienko OV; Bezus'ko AG; Shavaran SS
    Vrach Delo; 1989 Jul; (7):69-72. PubMed ID: 2800508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hemodynamic complication of verapamil therapy in a neonate.
    Abinader E; Borochowitz Z; Berger A
    Helv Paediatr Acta; 1981 Nov; 36(5):451-5. PubMed ID: 7309534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological aspects of the effect of glucocorticoids on the blood supply and activity of the heart (a review)].
    Seliverstov SA; Sviridov NK
    Farmakol Toksikol; 1975; 38(3):361-6. PubMed ID: 776653
    [No Abstract]   [Full Text] [Related]  

  • 30. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
    Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Brenna S; Bonacina E; Vignati S
    Fundam Clin Pharmacol; 2004 Dec; 18(6):657-67. PubMed ID: 15548237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Injectable verapamil as an arterial hypotensive drug--experimental study].
    Mateos DA; Tsuzuki S; Nakiri K; Bittencourt D; Zerbini EJ
    Arq Bras Cardiol; 1977 Jun; 30(3):221-6. PubMed ID: 921571
    [No Abstract]   [Full Text] [Related]  

  • 32. Verapamil abolishes exercise-induced regional contractile dysfunction in dogs.
    Schneider W; Ehrendorfer S; Krumpl G; Mayer N; Raberger G
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):103-10. PubMed ID: 3361978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verapamil in treatment of chronic stable angina.
    Frishman WH; Charlap S
    Arch Intern Med; 1983 Jul; 143(7):1407-15. PubMed ID: 6135403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electrophysiological effects of anti-arrhythmic calcium-antagonistic drugs in patients with conduction disorders: preliminary observations on verapamil].
    Jacovella G; Vajola FS; Floris B; Citone C; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(12):1645-51. PubMed ID: 1234461
    [No Abstract]   [Full Text] [Related]  

  • 35. [The anti-ischemic properties of verapamil and its effect on myocardial functional potentials in coronary artery occlusion].
    Paperno AA; Kovalev GV; Gurbanov KG
    Farmakol Toksikol; 1991; 54(2):26-8. PubMed ID: 1884790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Verapamil in a single dose, evaluation by means of the ergometric test].
    Pereira MH; Brito FS; Pereira CB; Lion MF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():83-94. PubMed ID: 889475
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electrophysiologic effects of verapamil in patients with conduction disturbances. Studies of 16 cases by recording of the electrocardiogram of the bundle of His].
    Jacovella G; Vajola FS; Floris B; Citone C; Page F; Milazzotto F
    Clin Ter; 1976 Oct; 79(1):63-72. PubMed ID: 1017164
    [No Abstract]   [Full Text] [Related]  

  • 38. [Electrophysiological effect of verapamil (studies in patients with normal A-V conduction and with WPW syndrome)].
    García Civera R; Sanjuan Máñez R; López Camps V; Rodríguez Serra M; Blanquer Oliva R; Llacer Escorihuela A; Llavador Sanchis J
    Rev Esp Cardiol; 1976; 29(6):525-36. PubMed ID: 796911
    [No Abstract]   [Full Text] [Related]  

  • 39. An experimental contribution to the treatment of acute myocardial infarction.
    Vrána M; Hess L; Vránová Z; Fejfar Z
    Czech Med; 1987; 10(3):142-55. PubMed ID: 2889585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.
    Bova S; Cargnelli G; D'Amato E; Forti S; Yang Q; Trevisi L; Debetto P; Cima L; Luciani S; Padrini R
    Br J Pharmacol; 1997 Jan; 120(1):19-24. PubMed ID: 9117093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.